Heinz-Otto Peitgen
Director/Board Member at Jacobs University Bremen
Profile
Heinz-Otto Peitgen is the founder of MeVis Medical Solutions AG, which was founded in 1997.
He is currently the Director at the University of Graz, a Non-Executive Director at Brainomix Ltd., a Member-Governors Board at Jacobs University Bremen, a Professor at the University of Bremen, and a Trustee at Zentrum für Kunst und Medientechnologie and Stiftung Bremer Wertpapierbörse.
Heinz-Otto Peitgen active positions
| Companies | Position | Start |
|---|---|---|
| Jacobs University Bremen | Director/Board Member | 01/01/2013 |
| Zentrum für Kunst und Medientechnologie | Director/Board Member | 01/01/2002 |
| University of Bremen | Corporate Officer/Principal | 01/01/1977 |
| University of Graz | Director/Board Member | 01/01/2003 |
| Stiftung Bremer Wertpapierbörse | Director/Board Member | - |
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 12/10/2020 |
Former positions of Heinz-Otto Peitgen
| Companies | Position | End |
|---|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Technology Services |
| Private companies | 3 |
|---|---|
| Zentrum für Kunst und Medientechnologie | |
| Stiftung Bremer Wertpapierbörse | |
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Heinz-Otto Peitgen
